Edit |   |
---|---|
Antigenic Specificity | CD20 (Rituximab biosimilar) |
Clone | monoclonal |
Host Species | Chimeric |
Reactive Species | n/a |
Isotype | IgG1 kappa |
Format | purified |
Size | 500ug |
Concentration | n/a |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | CD20 (Rituximab biosimilar). Rituximab biosimilar is a chimeric monoclonal antibody recombinantly expressed from human 293 cells (HEK293), which combines the variable region of a mouse monoclonal antibody with human IgG1 constant domain. The mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with CD20. |
Immunogen | n/a |
Other Names | n/a |
Gene, Accession # | n/a |
Catalog # | CD0-M36-500ug |
Price | $400 |
Order / More Info | CD20 (Rituximab biosimilar) Antibody from ACROBIOSYSTEMS USA |
Product Specific References | n/a |
China Office:
ACROBIOSYSTEMS China
Room 109, No. 3 Disheng Middle St., BDA,
Beijing, 100176 China
Tel: +86 400-685-2052
Fax: +86 10-5885-0566